FINANCING TREATMENT FOR SUBSTANCE ABUSE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
Saved in:
PAULY, M.V., FINANCING TREATMENT FOR SUBSTANCE ABUSE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT. ROCKVILLE,MD (USA), NATIONAL INSTITUTE ON DRUG ABUSE, 1991, 165-174 p.
Ref.
35331
Location:
SIIS Q1.104 D93.3
Palabras clave:
Drogodependencias, Evaluación, Financiación, Predicción, Tratamiento, EE.UU.
Drogodependencias, Evaluación, Financiación, Predicción, Tratamiento, EE.UU.
Similar Items: FINANCING TREATMENT FOR SUBSTANCE ABUSE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- COMMUNITY-BASED DRUG TREATMENT REIMBURSEMENT: PROGRESS AND BARRIERS. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT. NIDA RESEARCH MONOGRAPH SERIES Nº 113
- EVALUATING THE COST-EFFECTIVENESS OF DRUG ABUSE TREATMENT SERVICES. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- FINANCING AND COST OF STANDARD AND ENHANCED METHADONE TREATMENT
- POLICY-RELEVANT RESEARCH ON DRUG TREATMENT. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT
- FORECASTING THE COST OF DRUG ABUSE TREATMENT COVERAGE IN PRIVATE HEALTH INSURANCE. EN: ECONOMIC COSTS, COST-EFFECTIVENESS, FINANCING, AND COMMUNITY-BASED DRUG TREATMENT